Skip to main content
. Author manuscript; available in PMC: 2018 Feb 27.
Published in final edited form as: J Surg Oncol. 2015 Feb 24;111(6):690–695. doi: 10.1002/jso.23868

Figure 4.

Figure 4

Hypothetical illustration of the advantage of a nomogram. This patient has stage III disease according to both the AJCC/UICC and MSK staging systems. However the nomogram provides patient-specific information. She has an approximately 77% chance of dying of her disease in the next 12 years.